Free Trial

A. D. Beadell Investment Counsel Inc. Takes Position in MetLife, Inc. $MET

MetLife logo with Finance background

Key Points

  • A. D. Beadell Investment Counsel Inc. has acquired a new stake in MetLife, purchasing 3,590 shares valued at approximately $288,000.
  • MetLife reported Q2 earnings of $2.02 per share, missing analysts' expectations, with revenues also falling short at $17.34 billion.
  • The company announced a quarterly dividend of $0.5675, reflecting an annualized yield of 2.8% and a payout ratio of 38.47%.
  • Interested in MetLife? Here are five stocks we like better.

A. D. Beadell Investment Counsel Inc. purchased a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 3,590 shares of the financial services provider's stock, valued at approximately $288,000.

Several other large investors have also recently modified their holdings of the business. Dakota Wealth Management raised its stake in shares of MetLife by 18.6% during the second quarter. Dakota Wealth Management now owns 5,958 shares of the financial services provider's stock valued at $479,000 after acquiring an additional 935 shares during the last quarter. TD Private Client Wealth LLC raised its holdings in MetLife by 7.6% during the 2nd quarter. TD Private Client Wealth LLC now owns 68,219 shares of the financial services provider's stock worth $5,486,000 after purchasing an additional 4,829 shares during the last quarter. Foster Victor Wealth Advisors LLC raised its holdings in MetLife by 2.1% during the 2nd quarter. Foster Victor Wealth Advisors LLC now owns 137,966 shares of the financial services provider's stock worth $10,794,000 after purchasing an additional 2,875 shares during the last quarter. Northside Capital Management LLC bought a new position in MetLife during the 2nd quarter worth approximately $552,000. Finally, Ballentine Partners LLC raised its holdings in MetLife by 27.7% during the 2nd quarter. Ballentine Partners LLC now owns 18,149 shares of the financial services provider's stock worth $1,460,000 after purchasing an additional 3,942 shares during the last quarter. Institutional investors own 94.99% of the company's stock.

MetLife Trading Down 0.5%

NYSE MET opened at $80.28 on Friday. The company has a market cap of $53.39 billion, a price-to-earnings ratio of 13.61, a P/E/G ratio of 0.73 and a beta of 0.87. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $89.05. The business has a 50 day moving average price of $78.59 and a 200-day moving average price of $78.12. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57.

MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). The company had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The firm's revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.28 EPS. As a group, equities analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th were issued a $0.5675 dividend. The ex-dividend date of this dividend was Tuesday, August 5th. This represents a $2.27 annualized dividend and a dividend yield of 2.8%. MetLife's dividend payout ratio is currently 38.47%.

Analyst Ratings Changes

Several research analysts have issued reports on MET shares. Cowen restated a "buy" rating on shares of MetLife in a report on Friday, August 22nd. Morgan Stanley lowered their price target on shares of MetLife from $98.00 to $94.00 and set an "overweight" rating for the company in a report on Monday, August 18th. Piper Sandler lowered shares of MetLife from an "overweight" rating to a "neutral" rating and set a $84.00 price target for the company. in a report on Friday, September 19th. UBS Group lowered their price target on shares of MetLife from $94.00 to $91.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Finally, JPMorgan Chase & Co. increased their price target on MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat, MetLife currently has a consensus rating of "Moderate Buy" and a consensus price target of $94.64.

View Our Latest Research Report on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.